| Financial Year |
March 31 2023 |
| Monetary Funds |
2,850,563,052.61 |
| Held-for-trading Financial Assets |
1,220,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
134,244,625.17 |
| Advances to Suppliers |
153,275,315.31 |
| Other Receivables |
36,392,061.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
555,536,932.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,731,748.20 |
| Total Current Assets |
4,971,030,522.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
47,545,887.56 |
| Investment Properties |
-- |
| Fixed Assetes |
1,436,269,758.58 |
| Under-construction Projects |
16,714,338.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
367,185,906.00 |
| R&D expenses |
-- |
| Goodwill |
91,773,652.38 |
| Long-Term Deferred and Prepaid Expenses |
6,353,211.76 |
| Deferred Income Tax Assets |
60,283,070.38 |
| Other Non-Current Assets |
7,096,945.79 |
| Sub-Total of Non-Current Assets |
2,140,918,382.43 |
| Total Assets |
7,111,948,904.92 |
| Short-Term Loans |
430,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
821,731,235.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
108,218,296.62 |
| Taxes Payable |
153,471,240.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
141,223,736.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,798,775.39 |
| Other Current Liabilities |
18,568,496.28 |
| Sub-Total of Current Liabilities |
1,818,326,944.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,210,049.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
411,988,936.97 |
| Total Liabilities |
2,230,315,881.43 |
| Paid-In Capital(Or Share Stock) |
584,000,000.00 |
| Capital Surplus |
897,378,623.88 |
| Surplus Reserve |
299,866,501.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,822,645,709.20 |
| Minority Stockholder's Interest |
263,195,153.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,618,437,870.45 |
| Owner's Equity（Stockholder's Equity） |
4,881,633,023.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,111,948,904.92 |
